200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 127925-01-3

127925-01-3

127925-01-3 | 3-Isoxazolol

CAS No: 127925-01-3 Catalog No: AG000XKB MDL No:

Product Description

Catalog Number:
AG000XKB
Chemical Name:
3-Isoxazolol
CAS Number:
127925-01-3
Molecular Formula:
C3H3NO2
Molecular Weight:
85.0614
IUPAC Name:
1,2-oxazol-3-one
InChI:
InChI=1S/C3H3NO2/c5-3-1-2-6-4-3/h1-2H,(H,4,5)
InChI Key:
FUOSTELFLYZQCW-UHFFFAOYSA-N
SMILES:
Oc1ccon1

Properties

Complexity:
97  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
85.016g/mol
Formal Charge:
0
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
85.062g/mol
Monoisotopic Mass:
85.016g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
38.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.3  

Literature

Title Journal
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. Journal of medicinal chemistry 20111013
Isoxazol-5(4H)one derivatives as PTP1B inhibitors showing an anti-obesity effect. Chemistry, an Asian journal 20110801
Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors. Nature chemical biology 20110701
4-(2-Hydroxy-benzyl-idene)-3-methyl-isoxazol-5(4H)-one. Acta crystallographica. Section E, Structure reports online 20091201
(Z)-4-[4-(Dimethyl-amino)benzyl-idene]-3-methyl-isoxazol-5(4H)-one. Acta crystallographica. Section E, Structure reports online 20091201
Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20080902
Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site. Journal of medicinal chemistry 20080814
Isoxazolone based inhibitors of p38 MAP kinases. Journal of medicinal chemistry 20080424
4-(4-Fluoro-phen-yl)-2-methyl-3-(1-oxy-4-pyridyl)isoxazol-5(2H)-one. Acta crystallographica. Section E, Structure reports online 20080201
Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS neglected tropical diseases 20080101
4-[4-(4-Fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide-4-[3-(4-fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide (0.6/0.4). Acta crystallographica. Section E, Structure reports online 20080101
Polymorph formation studied by 3D nucleation simulations. Application to a yellow isoxazolone dye, paracetamol, and L-glutamic acid. The journal of physical chemistry. B 20070222
An easy synthesis of 5-functionally substituted ethyl 4-amino-1-aryl- pyrazolo-3-carboxylates: interesting precursors to sildenafil analogues. Beilstein journal of organic chemistry 20070101
Investigation of the UV/visible absorption spectra of merocyanine dyes using time-dependent density functional theory. The journal of physical chemistry. A 20061207
Replacement of the metabolically labile methyl esters in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors with isoxazolone, isoxazole, oxazolone, or cyano substituents. Journal of medicinal chemistry 20060824
The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production. Bioorganic & medicinal chemistry letters 20050502
Experimental and computational growth morphology of two polymorphs of a yellow isoxazolone dye. Langmuir : the ACS journal of surfaces and colloids 20050426
Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. Journal of medicinal chemistry 20050127
Stereoselectivity and regioselectivity in nucleophilic ring opening in derivatives of 3-phenylisoxazolo[2,3-a]pyrimidine. Unpredicted dimerization and ring transformation. Syntheses of derivatives of pyrimidinylmethylamine, pyrimidinylmethylamino acid amides, and alpha-amino-2-pyrimidinylacetamides. The Journal of organic chemistry 20040723
Design and synthesis of a new series of 4-alkylated 3-isoxazolol GABA A antagonists. European journal of medicinal chemistry 20030401
GluR2 ligand-binding core complexes: importance of the isoxazolol moiety and 5-substituent for the binding mode of AMPA-type agonists. FEBS letters 20021106
Activity of novel 4-PIOL analogues at human alpha 1 beta 2 gamma 2S GABA(A) receptors--correlation with hydrophobicity. European journal of pharmacology 20020913
Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling. Journal of medicinal chemistry 20020606
Novel non-steroidal/non-anilide type androgen antagonists with an isoxazolone moiety. Bioorganic & medicinal chemistry 20020501

Related Products

© 2019 Angene International Limited. All rights Reserved.